Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Celadon Pharmaceuticals PLC, a leading UK-based company specializing in cannabis-based medicines, has successfully passed all resolutions at its recent Annual General Meeting. The company is known for its EU-GMP approved 100,000 sq. ft facility that focuses on improving life quality for chronic pain and autism conditions through advanced cannabis research and products. Investors can find the detailed poll results on Celadon’s official website.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
